Unbound MEDLINE

Drug delivery studies in Caco-2 monolayers. Synthesis, hydrolysis, and transport of O-cyclopropane carboxylic acid ester prodrugs of various beta-blocking agents. Pharmaceutical research. [Pharm Res] Journal article

 
TitleDrug delivery studies in Caco-2 monolayers. Synthesis, hydrolysis, and transport of O-cyclopropane carboxylic acid ester prodrugs of various beta-blocking agents.
Author(s)Hovgaard L, Brøndsted H, Buur A, Bundgaard H 
InstitutionRoyal Danish School of Pharmacy, Department of Pharmaceutics, Copenhagen O.
SourcePharm Res 1995 Mar; 12(3):387-92.
MeSHAcebutolol
Adrenergic beta-Antagonists
Alprenolol
Cells, Cultured
Drug Delivery Systems
Esters
Humans
Hydrolysis
Mathematics
Permeability
Time Factors
AbstractA series of O-cyclopropane carboxylic acid ester prodrugs of various beta-blocking agents was synthesized. All prodrugs were hydrolyzed to give their parent compounds in aqueous phosphate buffer of pH 7.4 and in 80% human plasma. The half-lives in buffer solutions varied from 4 hours for the timolol prodrug to about 1 day for the prodrug of alprenolol. In human plasma the half-lives were shorter, ranging from 1 to 7 hours. The formation of the O-cyclopropane carboxylic acid ester derivatives significantly increased the lipophilicities of the beta-blockers as measured by the distribution coefficient between n-octanol and aqueous phosphate buffer of pH 7.4. To characterize the biomembrane permeability characteristics of the beta-blockers, transport properties across Caco-2 cell monolayers were investigated. An increase in lipophilicity resulted in a higher permeability of the prodrugs as compared to the parent compounds. Hence, acebutolol experienced an increment of a factor 17 on the apparent permeability coefficient, Papp, whereas Papp for the more lipophilic drug propranolol was increased by a factor of only 1.26. Some conversion of the prodrugs to their parent compounds was observed during the transport and appeared to be due to enzymatic intracellular metabolism.
Languageeng
Pub Type(s)Journal Article
PubMed ID7617526
  
Advertise on this site.